Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Latin America News Hub.
Press releases published on September 3, 2025

Royalton Riviera Cancun To Debut a Reimagined All-Inclusive Experience With Royalton Hotels & Resorts
CANCUN, Mexico, Sept. 03, 2025 (GLOBE NEWSWIRE) -- The recently formed Royalton Hotels …

Royalton Riviera Cancun presentará una experiencia todo incluido reimaginada junto a Royalton Hotels & Resorts
CANCÚN, México, Sept. 03, 2025 (GLOBE NEWSWIRE) -- La recientemente formada Royalton Hotels …

BVI Unveils Virtuoso® – A Novel Dual-Function Surgical Platform for Cataract and Vitreoretinal Procedures
BVI announces Virtuoso®, its first dual-function phaco-vitrectomy system designed to deliver advanced control, efficiency, and versatility for both cataract and vitreoretinal surgery. European debut planned for 2025 Global ophthalmic congresses in Europe ( …

Critical Metals Corp NASDAQ CRML Reports Massive Mineralization Extension & Continues Resource Expansion These (3) 2024 Drilling Holes Intercepted Exceptional Rare Earth Elements Grading TREO Range 0.40% to 0.42% & HREO ∼26% Across our Flagship Core…
NEW YORK, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Critical Metals Corp. (Nasdaq: CRML) (“Critical Metals Corp” or the “Company”), a leading critical minerals mining company, today announced for the first time three new assay results from the 2024 diamond drill …

Jalisco to Shine as Global Spirits Competition Arrives This September
Photo Credit: Jalisco Ministry of Tourism Secretary of Tourism for Jalisco, Michelle Fridman Hirsch, with Concours Mondial de Bruxelles Organizers JALISCO, Mexico, Sept. 03, 2025 (GLOBE NEWSWIRE) -- From September 7–12, 2025, one of the world’s most …

Persephoni Launches Strategic Sponsorship with American Cancer Society’s BrightEdge to Accelerate Oncology Innovation
RESEARCH TRIANGLE PARK, N.C., Sept. 03, 2025 (GLOBE NEWSWIRE) -- Persephoni BioSciences LLC ("Persephoni"), a leading global life sciences venture studio, is proud to announce a $1.5 million sponsorship to American Cancer Society BrightEdge LLC (" …

GRI Bio to Present at the H.C. Wainwright 27th Annual Global Investment Conference
Live webcast presentation with CEO, Dr. Marc Hertz, on September 9th at 3:00 PM ET LA JOLLA, CA, Sept. 03, 2025 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing an innovative pipeline of …

Directo lanza agente de voz con IA para transformar la atención al cliente en la banca en México
CIUDAD DE MÉXICO, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Directo, proveedor mexicano de soluciones de comunicación, anunció el lanzamiento de su agente conversacional de inteligencia artificial (IA) adas entrantes, tras alcanzar el hito de 1,000 conversaciones …

Directo Launches AI Voice Agent to Transform Customer Service in Mexican Banking
MEXICO CITY, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Directo, a Mexican provider of communication solutions, has announced the launch of its AI-powered voice agent for inbound calls, following a key milestone: 1,000 successful phone conversations in which users …

AlphaTON Capital Corp Launches TON Digital Asset Treasury Strategy for the Telegram Ecosystem
DOVER, DE, Sept. 03, 2025 (GLOBE NEWSWIRE) -- AlphaTON Capital Unlocks Public Market Access to Toncoin (TON) and Telegram’s Billion-User Ecosystem Brittany Kaiser, pioneer in data protection, digital assets, and the public equity markets appointed Chief …

Volaris Reports August 2025 Traffic Results: Load Factor of 85%
MEXICO CITY, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Controladora Vuela Compañía de Aviación, S.A.B. de C.V. (NYSE: VLRS and BMV: VOLAR) (“Volaris” or “the Company”), the ultra-low-cost carrier (ULCC) serving Mexico, the United States, Central and South America …

Outlook Therapeutics to Present at the 2025 EURETINA Innovation Spotlight (EIS)
ISELIN, N.J., Sept. 03, 2025 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on optimizing the standard of care for bevacizumab for the treatment of retina diseases, today announced that it will present at …

Achieve Life Sciences Announces FDA Acceptance of Cytisinicline New Drug Application for Treatment of Nicotine Dependence for Smoking Cessation
Filing based on pivotal Phase 3 ORCA-2 and ORCA-3 clinical trials demonstrating statistically significant and clinically meaningful smoking cessation FDA acceptance starts the review process and sets timing for potentially the first new FDA-approved …

Silo Pharma Secures Australian Patent Covering Licensed PTSD Drug Candidate Expanding Global IP Portfolio
SARASOTA, FL, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or “the Company), a diversified developmental-stage biopharmaceutical and cryptocurrency treasury company, today announced that IP Australia (the Australian Patent …

Assertio to Participate in the HC Wainwright and Lake Street Conferences in September 2025
LAKE FOREST, Ill., Sept. 03, 2025 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT) announced that members of its management team will host investor meetings at two investor conferences in New York City during …

Sensei Biotherapeutics to Participate in the H.C. Wainwright 27th Annual Global Investment Conference
BOSTON, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), a clinical stage biotechnology company focused on the discovery and development of next-generation therapeutics for cancer patients, today announced that John Celebi, …

Connect Biopharma Completes Termination of its American Depositary Receipt Program and Directly Lists its Ordinary Shares on Nasdaq
SAN DIEGO, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) (“Connect Biopharma” or the “Company”), a clinical-stage biopharmaceutical company focused on transforming care for the treatment of inflammatory diseases, …

Vaxart to Present at the H.C. Wainwright Global Investment Conference on September 8, 2025
SOUTH SAN FRANCISCO, Calif., Sept. 03, 2025 (GLOBE NEWSWIRE) -- SOUTH SAN FRANCISCO, Calif., September 2, 2025 — Vaxart, Inc. (OTCQX: VXRT), a clinical-stage biotechnology company developing a range of oral recombinant pill vaccines based on its …

Cocrystal Pharma to Participate at the H.C. Wainwright Global Investment Conference
BOTHELL, Wash., Sept. 03, 2025 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) (“Cocrystal” or the “Company”) announces that James Martin, CFO and co-CEO, will present a company overview at the H.C. Wainwright 27th Annual Global Investment …

LIXTE Biotechnology Holdings Appoints Two New Board Members and New Chief Financial Officer
-- Company Relocates Corporate Headquarters to Boca Raton -- Boca Raton, Fla., Sept. 03, 2025 (GLOBE NEWSWIRE) -- LIXTE Biotechnology Holdings, Inc. (“LIXTE” or the “Company”) (Nasdaq: LIXT and LIXTW), a clinical-stage pharmaceutical company developing a …